TNF and inflammatory bowel disease: The mRNA levels in some genes have been identified as pharmacogenomic biomarkers of the activity of anti-TNF drugs in the inflamed tissues of adults diagnosed with IBD or other autoimmune disorders [9,10,11,12,13].